Cargando…

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Mikami, Yoko, Cornhill, Aidan K, Merchant, Naeem, Lydell, Carmen P, Howarth, Andrew G, White, James A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032106/ http://dx.doi.org/10.1186/1532-429X-18-S1-P287

Ejemplares similares

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events
por: Mikami, Yoko, et al.
Publicado: (2016)

Prognostic significance of the extent of septal fibrosis quantified on late gadolium enhanced images in patients with nonischemic cardiomyopathy
por: Cornhill, Aidan K, et al.
Publicado: (2015)

Right ventricular insertion site fibrosis in a dilated cardiomyopathy referral population: phenotypic associations and value for the prediction of heart failure admission or death
por: Mikami, Yoko, et al.
Publicado: (2021)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
por: Lydell, Carmen P, et al.
Publicado: (2011)

Left atrial volume and function are predictive of cardiac death or appropriate device therapy in patients with non-ischemic dilated cardiomyopathy
por: Arasaratnam, Punitha, et al.
Publicado: (2016)

Mid-wall striae fibrosis predicts heart failure admission, composite heart failure events, and life-threatening arrhythmias in dilated cardiomyopathy
por: Purmah, Yanish, et al.
Publicado: (2022)

Multiplanar 4D strain analysis with spatial mapping to 3D LGE quantification: relationships in chronic Ischemic Cardiomyopathy
por: Satriano, Alessandro, et al.
Publicado: (2015)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Segmental strain analysis by deformation of a mesh model: comparison of segmental strain metrics and late gadolinium enhancement quantification in myocardial infarction
por: Satriano, Alessandro, et al.
Publicado: (2016)

Relative influence of peak strain delay and peak strain amplitude of non-scarred myocardium in response to cardiac resynchronization therapy: insights from segmental 4D strain analysis
por: Satriano, Alessandro, et al.
Publicado: (2016)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Refining the characterization of residual function in hypertrophic cardiomyopathy through remote segment 4D strain analysis
por: Satriano, Alessandro, et al.
Publicado: (2016)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

RE: Relation of Late Gadolinium Enhancement to Increased Ventricular Wall Stress in Dilated Cardiomyopathy
por: Alter, Peter
Publicado: (2016)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis
por: Feng, Xin-Yi, et al.
Publicado: (2023)

Histopathological validation of semi-automated myocardial scar quantification techniques for dark-blood late gadolinium enhancement magnetic resonance imaging
por: Nies, Hedwig M J M, et al.
Publicado: (2022)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
por: Mirelis, Jesús G., et al.
Publicado: (2022)

Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies
por: Boban, Marko, et al.
Publicado: (2018)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
por: Mueller, Karin A. L., et al.
Publicado: (2016)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy
por: Stirrat, John, et al.
Publicado: (2015)

Differentiation of physiologic versus pathologic basal septal fibrosis: Proposed diagnostic criteria and associations with clinical and CMR-based markers of cardiovascular disease
por: Joncas, Sebastien X, et al.
Publicado: (2014)

Smoking aggravates ventricular arrhythmic events in non-ischemic dilated cardiomyopathy associated with a late gadolinium enhancement in cardiac MRI
por: Park, Junbeom, et al.
Publicado: (2018)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
por: Mėlinytė-Ankudavičė, Karolina, et al.
Publicado: (2022)

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy
por: Holmström, Miia, et al.
Publicado: (2011)

Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy
por: Latus, Heiner, et al.
Publicado: (2015)

Case series: LMNA‐related dilated cardiomyopathy presents with reginal wall akinesis and transmural late gadolinium enhancement
por: Wang, Shuai, et al.
Publicado: (2020)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_61vv9ndf7gfg5aam3htt5s93lg